Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

Chikungunya is a mosquito-borne viral disease caused by the chikungunya virus and characterized primarily by fever and severe joint pain. According to Sijia Wang et al. (2026), global incidence increased from 0.28 per 100,000 in 2004 to 11.13 per 100,000 in 2024, with the Americas recording 43.9 per 100,000. As per the chikungunya epidemiology forecast by Expert Market Research, arboviral disease surveillance remains important for assessing its evolving burden.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

Chikungunya – Number of Cases by Year

Read more about this report - Request a Free Sample

Chikungunya Epidemiology Forecast Report Coverage

Expert Market Research's “Chikungunya Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of chikungunya. It projects the future incidence and prevalence rates of chikungunya cases across various populations. The study covers age, gender, and type as major determinants of the chikungunya population. The report highlights patterns in the prevalence of chikungunya over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of chikungunya in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Chikungunya Understanding: Disease Overview

Chikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV), an alphavirus primarily transmitted to humans through infected Aedes aegypti and Aedes albopictus mosquitoes. Infection commonly occurs after a mosquito bite and may produce sudden fever, severe joint pain, rash, headache, and muscle pain. Most patients develop an acute illness that resolves within days to weeks, although joint symptoms may persist for months or longer in some individuals. Chikungunya is generally classified as acute chikungunya infection and chronic or persistent chikungunya-associated arthralgia.

Key Report Insights

Parameter

Insight

Largest Patient Pool

India

Fastest Growing Country

India

High-Risk Population

Older adults, infants, and individuals with underlying health conditions

Key Diagnostic Method

Reverse transcription polymerase chain reaction (RT-PCR) and serological testing

Major Risk Factor

Exposure to infected Aedes mosquitoes

Major gap in the market

Limited disease-specific antiviral and preventive treatment options

Chikungunya Epidemiology Perspective

The chikungunya epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the chikungunya epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for chikungunya and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

According to Sijia Wang et al. (2026), the incidence of autochthonous chikungunya increased from 0.28 per 100,000 in 2004 to 11.13 per 100,000 in 2024. In 2024, the Americas recorded the highest incidence, at 43.9 per 100,000, corresponding to 431,305 cases.

Gender-Specific Cases of the Disease

As per Aline do Carmo Silva et al. (2023), chikungunya cases reviewed across Northeast Brazil predominantly affected females. Across the included studies, female representation ranged from 7.5% to 100.0%, indicating considerable variation in the gender distribution of reported cases.

Age-Specific Cases of the Disease

According to World Health Organization (2025), among locally reported chikungunya cases as of August 16, 2025, individuals aged 18–45 years represented 37.0% of cases, followed by those aged 46–60 years at 23.3% and 61–74 years at 15.2%.

Ethnicity-Wise Cases of the Disease

According to Vaneide Daciane Pedí et al. (2025), among 7,421 chikungunya hospitalizations recorded in Brazil during 2014–2024, 63.5% involved individuals identifying as brown or Black. This distribution provides an epidemiological perspective on ethnicity among hospitalized patients.

Mortality and Survival Analysis of the Disease

As per Vaneide Daciane Pedí et al. (2025), the overall in-hospital case-fatality rate among chikungunya hospitalizations in Brazil was 1.1%. Mortality increased substantially with age, reaching 11.5% among patients older than 90 years and 14.1% among men aged 85–89 years.

Chikungunya – Number of Cases by Country

Read more about this report - Request a Free Sample

Country-wise Chikungunya Epidemiology

The Chikungunya epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

According to William M. de Souza et al. (2024), chikungunya continues to circulate across the Americas, with 3.7 million suspected and laboratory-confirmed cases reported across 50 countries and territories since its emergence in the region in 2013. The available data demonstrate substantial regional epidemiological activity.

Germany

According to Qian Liu et al. (2025), Germany accounted for 14.5% of the 4,730 chikungunya cases documented across mainland Europe during 2007–2022. Most European infections were travel-related, while reported incidence varied by country and year and showed a seasonal pattern associated with summer travel.

France

As per Qian Liu et al. (2025), France accounted for 19.6% of chikungunya cases documented across mainland Europe during 2007–2022. Autochthonous outbreaks were reported in France in 2014 and 2017, while most infections across mainland Europe were travel-related.

Italy

According to Qian Liu et al. (2025), Italy represented 13.6% of the 4,730 chikungunya cases reported across mainland Europe during 2007–2022. Autochthonous transmission was documented in Italy in 2007, while travel-related infections constituted the majority of chikungunya cases reported across Europe.

Spain

As per Qian Liu et al. (2025), chikungunya epidemiology in mainland Europe demonstrated substantial variation in incidence between countries and years. Most infections were travel-related, with reported cases showing seasonal patterns associated primarily with summer vacation. Spain forms part of this broader European epidemiological pattern.

United Kingdom

According to Qian Liu et al. (2025), the United Kingdom accounted for 21.9% of the 4,730 chikungunya cases documented across mainland Europe during 2007–2022, representing the largest country-level share. Most European infections were travel-related and exhibited seasonal patterns associated with summer travel.

Japan

According to Sijia Wang et al. (2026), recurrent local chikungunya outbreaks occurred in several countries across the Western Pacific region. The study identified substantial regional heterogeneity in incidence, while chikungunya activity in temperate regions generally remained sporadic compared with higher-burden tropical regions.

India

According to Qian Liu et al. (2025), India was the most frequently reported origin of travel-related chikungunya infections documented in mainland Europe, accounting for 11.7% of infections acquired abroad. As per Sijia Wang et al. (2026), South-East Asia recorded 258,854 cases and an incidence of 14.3 per 100,000 in 2024.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

A major gap in the chikungunya disease landscape is the absence of a widely available disease-specific antiviral treatment, leaving clinical management largely supportive. Another important unmet need is timely and accurate diagnosis because chikungunya can present symptoms overlapping those of dengue and other febrile illnesses. Opportunities exist for improved molecular and serological diagnostics, particularly in regions with recurring outbreaks such as India. Continued development and uptake of preventive approaches, including vaccines and mosquito-control measures, may further address the disease burden. The growing recognition of persistent joint symptoms also creates opportunities for longer-term post-infection care.

Chikungunya: Treatment Overview

There is currently no widely approved antiviral treatment specifically targeting chikungunya. Management is primarily supportive and focuses on reducing fever, relieving joint pain, maintaining hydration, and supporting recovery. Acetaminophen is generally used initially for fever and pain relief, while nonsteroidal anti-inflammatory drugs may be considered after dengue has been excluded because of the risk of bleeding associated with dengue infection. Adequate fluids and rest are also recommended. Patients with persistent joint symptoms may require medical evaluation and longer-term chikungunya arthritis management, including physical therapy and specialist-directed treatment.

Key Questions Answered

  • What is the current and projected burden of chikungunya across the 8 major markets?
  • Which countries across the 8 major markets account for the highest chikungunya patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of chikungunya across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of chikungunya across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of chikungunya across the 8 major markets?
  • How do major comorbidities and risk factors influence chikungunya epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of chikungunya across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the chikungunya landscape across the 8 major markets?
  • Which therapeutic areas linked to chikungunya are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the Chikungunya epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on chikungunya epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for chikungunya across the 8 major markets?

Scope of the Chikungunya Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of chikungunya based on several factors.
  • Chikungunya Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The chikungunya report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Dengue Testing Market

Dengue Pipeline Analysis

Malaria Diagnostics Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us